Comparison of Mean Platelet Volume in Patients with and Without Diabetes Mellitus at a Tertiary Care Hospital

Jahanzaib  Ashraf; Uffaq  Farrukh; Amanullah  Bhalli; Uneeba  Syed

doi:10.54112/bcsrj.v6i3.1607

Authors

Jahanzaib Ashraf Department of Medicine, Akhtar Saeed Trust Hospital Lahore, Pakistan
Uffaq Farrukh Department of Medicine, Akhtar Saeed Trust Hospital Lahore, Pakistan
Amanullah Bhalli Department of Diabetes and Endocrinology, Jinnah hospital Lahore, Pakistan
Uneeba Syed Department of Endocrinology, Allama Iqbal medical college/Jinnah hospital Lahore, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i3.1607

Keywords:

Biomarkers, Blood Platelets, Diabetes Mellitus, Mean Platelet Volume, Thrombosis

Abstract

Mean Platelet Volume (MPV) is a platelet activation marker linked to various cardiovascular diseases. Type 2 Diabetes Mellitus (T2DM) is known to increase the risk of thrombosis, and changes in platelet characteristics, including MPV, may contribute to this risk. Objective: This study aimed to compare the MPV in patients with and without T2DM at a tertiary care hospital. Methods: This randomized controlled trial was conducted at Akhtar Saeed Trust Hospital, Lahore, with 98 participants (49 diabetic and 49 non-diabetic) from 18 October 2024 Till 17 January 2025. Data were collected through non-probability consecutive sampling. MPV, fasting blood glucose (FBG), and HbA1c were measured for each patient. Results: The mean MPV was significantly higher in the diabetic group (9.94 ± 1.07 fL) compared to the non-diabetic group (9.36 ± 0.96 fL), with a p-value of 0.001. FBG and HbA1c levels were also significantly higher in the diabetic group. Stratified analysis showed consistent results across age and BMI categories, confirming that these factors did not confound the difference in MPV. Conclusion: It is concluded that T2DM is associated with higher MPV, suggesting increased platelet activation in diabetic patients. This may contribute to the elevated cardiovascular risk observed in this population. MPV could potentially serve as a biomarker for platelet dysfunction in diabetes, but further research is needed to explore its clinical significance and predictive value.

Downloads

Download data is not yet available.

References

Arkew M, Yemane T, Mengistu Y, Gemechu K, Tesfaye G. Hematological parameters of type 2 diabetic adult patients at Debre Berhan Referral Hospital, Northeast Ethiopia: A comparative cross-sectional study. PLOS ONE. 2021;16(6):e0253286.

Gulia M, Gupta M, Singh Lehl S, Singla M, Tahlan A, Kaur J. Mean platelet volume and glycaemic control in patients with new-onset Type 2 diabetes mellitus. Journal of the Royal College of Physicians of Edinburgh. 2022;52(2):105-9.

Agu KC. Diabetes mellitus: A review of some prognostic markers of response to treatment and management. Journal of Insulin Resistance. 2018;3(1):1-10.

Tajarernmuang P, Phrommintikul A, Limsukon A, Pothirat C, Chittawatanarat K. The role of mean platelet volume as a predictor of mortality in critically ill patients: a systematic review and meta‐analysis. Critical care research and practice. 2016;2016(1):4370834.

Pogorzelska K, Krętowska A, Krawczuk-Rybak M, Sawicka-Żukowska M. Characteristics of platelet indices and their prognostic significance in selected medical conditions–a systematic review. Advances in Medical Sciences. 2020;65(2):310-5.

Gadwal S. Mean Platelet Volume in Type 2 Diabetes Mellitus: Rajiv Gandhi University of Health Sciences (India); 2019.

Alhadas KR, Santos SN, Freitas MMS, Viana SMS, Ribeiro LC, Costa MB. Are platelet indices useful in the evaluation of type 2 diabetic patients? Jornal Brasileiro de Patologia e Medicina Laboratorial. 2016;52:96-102.

Kodiatte TA, Manikyam UK, Rao SB, Jagadish TM, Reddy M, Lingaiah HKM, et al. Mean platelet volume in type 2 diabetes mellitus. Journal of Laboratory Physicians. 2012;4(01):005-9.

Vernekar PV, Vaidya KA. Comparison of mean platelet volume in type 2 diabetics on insulin therapy and on oral hypoglycaemic agents. Journal of clinical and diagnostic research: JCDR. 2013;7(12):2839.

Saluja M, Swami YK, Meena S. Study of Impact of Glycemic Status (HbA1c) on Platelet Activity measured by Mean Platelet Volume & Vascular Complications in Diabetics. The Journal of the Association of Physicians of India. 2019;67(4):26-9.

Li X, Weber NC, Cohn DM, Hollmann MW, DeVries JH, Hermanides J, et al. Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis. Journal of clinical medicine. 2021;10(11):2419.

Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge A, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice. 2018;138:271-81.

Hulst AH, Visscher MJ, Cherpanath TG, van de Wouw L, Godfried MB, Thiel B, et al. Effects of liraglutide on myocardial function after cardiac surgery: a secondary analysis of the randomised controlled GLOBE trial. Journal of Clinical Medicine. 2020;9(3):673.

Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators of inflammation. 2019;2019(1):9213074.